Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece by The Business Journals cited an article published in a supplement to The American Journal of Managed Care® (AJMC®). The article, “Utilizing Oncology Biosimilars to Minimize the Economic Burden Associated With Cancer Treatment: Managed Care Considerations,” discussed pharmacists’ role in providing consistent messaging about biosimilars to both health care professionals and patients with cancer.
A story by BestLife referenced a study published in a supplement to AJMC®, titled “The Economic Impact of Peanut Allergies.” The study addressed the direct and indirect costs related to peanut allergies, which affect an estimated 1.2% of the overall US population and about 2.5% of the pediatric population.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More